| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9960261 | Journal of the American College of Cardiology | 2005 | 8 Pages |
Abstract
Both ACEIs and ARBs appear to be effective in the prevention of AF. This benefit appears to be limited to patients with systolic left ventricular dysfunction or LV hypertrophy. The use of these drugs following cardioversion appears promising but requires further study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeff S. MD, Adrian MD, Eugene MD, Carlos A. MD, Michael BA, Salim MD, PhD, Stuart J. MD,